Hepatologist 'The Liver Doc' explains who should avoid the weight-loss medication Mounjaro and why it is necessary for some people.

Dr. Cyriac Abby Philips, a hepatologist, emphasizes that while Mounjaro can be beneficial for those who are obese, people who are at risk for certain health issues should stay away from it.



Since they became popular a few years ago, weight loss medications have drawn more criticism than acceptance. However, it's crucial to educate oneself before making judgments about them.

Hepatologist Dr. Cyriac Abby Philips, often known as The Liver Doc, provided a thorough analysis of Mounjaro in a piece published on September 9. She explained who should use it, who shouldn't, why it is revolutionary, and what potential side effects it may have.

Mounjaro is unnecessary.
For those who are unaware, Mounjaro is a medication that mimics the body's natural hormones that control blood sugar and hunger. It is comparable to other well-known weight-loss medications like Wegovy and Ozempic.

Regarding who need Mounjaro, the hepatologist explained that the following individuals ought to take it:

adults with type 2 diabetes who require improved glucose management, particularly if losing weight is a top concern.
adults who are obese (BMI ≥30) or who have a weight-related illness (BMI ≥27).
adults who suffer from obesity and moderate-to-severe obstructive sleep apnea.

Comments

Popular posts from this blog

This is when pre-orders for the iPhone 18 Pro and iPhone 18 Pro Max are expected to open.

World News Today Live Updates: Eight people are killed in a charter plane crash near a remote radar post in western Alaska

Trump directs the Pentagon to reduce cooperative drills with South Korea.